当前位置：
X-MOL 学术
›
Int. J. Impot. Res.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
"Doc, if it were you, what would you do?": a survey of Men's Health specialists' personal preferences regarding treatment modalities.
International Journal of Impotence Research ( IF 2.8 ) Pub Date : 2020-03-23 , DOI: 10.1038/s41443-020-0263-3 Maxwell Towe 1 , Farouk El-Khatib 2 , Mohamad Osman 2 , Linda Huynh 2 , Rafael Carrion 3 , Sam Ward 4 , Yavoc Reisman 5 , Ege Can Serefoglu 6 , Alexander Pastuszak 7 , Faysal A Yafi 2
International Journal of Impotence Research ( IF 2.8 ) Pub Date : 2020-03-23 , DOI: 10.1038/s41443-020-0263-3 Maxwell Towe 1 , Farouk El-Khatib 2 , Mohamad Osman 2 , Linda Huynh 2 , Rafael Carrion 3 , Sam Ward 4 , Yavoc Reisman 5 , Ege Can Serefoglu 6 , Alexander Pastuszak 7 , Faysal A Yafi 2
Affiliation
|
Men's Health is a urological subspecialty that is at the forefront of innovation, but little data exist evaluating the attitudes that andrologists have toward the current treatment modalities available for managing Men's Health conditions. A survey of 37 questions asking what providers would choose as treatment for common conditions was distributed online via Survey Monkey to members of the Sexual Medicine Society of North America and European Society for Sexual Medicine. A total of 115 respondents completed the survey after an initial screening question. For erectile dysfunction (ED), 40%, 38%, and 33% of providers indicated that they would use tadalafil daily, tadalafil on demand, or sildenafil on demand, respectively, as first-line phosphodiesterase 5 inhibitor therapy. Furthermore, a total of 74% would elect to undergo low-intensity shockwave therapy [67%], platelet rich plasma injections [15%], and stem cell injections [15%]. Sex/behavioral therapy was preferred for both premature (36%) and delayed (52%) ejaculation. Approximately 44% of respondents indicated that they would undergo Collagenase Clostridium Histolyticum injections for Peyronie's Disease in the acute phase. In the setting of hypogonadal symptoms with borderline low total testosterone levels (300-400 ng/dL), 69% of respondents would pursue testosterone therapy. The prostatic lift procedure was the preferred procedure for men seeking symptom resolution with preservation of ejaculatory function. Many Men's Health specialists would pursue the least invasive options before considering procedural intervention for any given condition. Providers may shift their treatment preferences toward newer treatment modalities as longer term data become available.
中文翻译：
“医生，如果是你，你会怎么做？”：对男性健康专家在治疗方式方面的个人偏好的一项调查。
男性健康是泌尿外科的一个专业领域，它处于创新的最前沿，但是很少有数据评估男科医师对当前可用于管理男性健康状况的治疗方式的态度。通过调查猴在线调查了37个问题，询问提供者会选择哪种治疗方法来治疗常见病，该调查已在线分发给了北美性医学学会和欧洲性医学学会会员。在初步筛选问题之后，共有115位受访者完成了调查。对于勃起功能障碍（ED），有40％，38％和33％的提供者表示他们将分别每天使用他达拉非，按需使用他达拉非或按需使用西地那非作为一线磷酸二酯酶5抑制剂治疗。此外，总共74％的人会选择接受低强度冲击波治疗[67％]，富血小板血浆注射[15％]和干细胞注射[15％]。早泄（36％）和延迟射精（52％）都优选进行性/行为疗法。大约44％的受访者表示，他们将在急性期接受用于治疗Peyronie病的胶原酶溶组织梭状芽孢杆菌注射。在总睾丸激素水平较低（300-400 ng / dL）的性腺功能减退症状的情况下，有69％的受访者会选择睾丸激素治疗。对于寻求症状缓解并保留射精功能的男性来说，前列腺举升手术是首选手术。许多男性健康专家会在考虑针对任何给定状况的程序干预之前，采用微创治疗方案。
更新日期：2020-04-24
中文翻译：
“医生，如果是你，你会怎么做？”：对男性健康专家在治疗方式方面的个人偏好的一项调查。
男性健康是泌尿外科的一个专业领域，它处于创新的最前沿，但是很少有数据评估男科医师对当前可用于管理男性健康状况的治疗方式的态度。通过调查猴在线调查了37个问题，询问提供者会选择哪种治疗方法来治疗常见病，该调查已在线分发给了北美性医学学会和欧洲性医学学会会员。在初步筛选问题之后，共有115位受访者完成了调查。对于勃起功能障碍（ED），有40％，38％和33％的提供者表示他们将分别每天使用他达拉非，按需使用他达拉非或按需使用西地那非作为一线磷酸二酯酶5抑制剂治疗。此外，总共74％的人会选择接受低强度冲击波治疗[67％]，富血小板血浆注射[15％]和干细胞注射[15％]。早泄（36％）和延迟射精（52％）都优选进行性/行为疗法。大约44％的受访者表示，他们将在急性期接受用于治疗Peyronie病的胶原酶溶组织梭状芽孢杆菌注射。在总睾丸激素水平较低（300-400 ng / dL）的性腺功能减退症状的情况下，有69％的受访者会选择睾丸激素治疗。对于寻求症状缓解并保留射精功能的男性来说，前列腺举升手术是首选手术。许多男性健康专家会在考虑针对任何给定状况的程序干预之前，采用微创治疗方案。
京公网安备 11010802027423号